STOCK TITAN

Relay Therapeutics, Inc. (RLAY) Revenue by Year

RLAY

Relay Therapeutics, Inc. generated $15.4M in revenue in fiscal year 2025. This represents an increase of 53.4% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Relay Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue $15.4M
YoY +53.4%
5Y CAGR -28.6%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

RLAY Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Revenue$15.4M+53.4%$10.0M-60.8%$25.5M+1749.8%$1.4M-54.4%$3.0M-96.3%$82.7MN/A

RLAY Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$350K-48.3%$3.0M-60.9%N/A$0$677K$7.7M-23.3%N/A$0-100.0%$0-100.0%$10.0M+4327.9%N/A$25.2M+7226.2%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Relay Therapeutics, Inc. financials

Frequently Asked Questions

What was Relay Therapeutics, Inc.'s revenue in fiscal year 2025?

Relay Therapeutics, Inc. generated $15.4M in revenue in fiscal year 2025.

How fast is Relay Therapeutics, Inc.'s revenue growing?

Relay Therapeutics, Inc. (RLAY) revenue rose by 53.4% year over year, from $10.0M to $15.4M in fiscal year 2025.

What was Relay Therapeutics, Inc.'s revenue in the most recent quarter?

Relay Therapeutics, Inc. (RLAY) reported $350K in revenue in Q2 2026. This represents a decrease of 48.3% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Relay Therapeutics, Inc. (RLAY) reported on that line in every period on record.